Evonik Industries AG – Third‑Quarter Performance and Outlook
Financial Highlights (Q3 2026)
| Item | Q3 2026 | Q3 2025 | Comment |
|---|---|---|---|
| Revenue | €3.825 billion | €3.391 billion | 13.5 % increase |
| Earnings (net) | –€53 million | –€106 million | Improvement in profitability |
| Earnings per share (EPS) | –€0.23 | –€0.11 | Narrower loss margin |
| Adjusted earnings | €128 million | – | €0.27 per share (adjusted) |
| Adjusted EBITDA | €629 million | €509 million | 40 % year‑over‑year rise |
| Guidance for 2026 | Upper half of forecasted EBITDA range | – | 2.0–2.2 billion EUR |
The company reported a higher revenue figure and a significant reduction in net loss compared with the same period last year. Adjusted earnings and EBITDA show a strong turnaround, driven by higher prices and volumes.
Management Commentary
- Optimism for Full‑Year Earnings: Management reiterated that the upper half of its forecasted EBITDA range for 2026 is likely to be achieved. The company cited a 40 % increase in adjusted EBITDA to €629 million versus €509 million a year earlier.
- Impact of Supply Disruptions: The company noted that supply disruptions in the Middle East benefited Evonik by shifting some demand toward its operations in Essen.
- Response to Acquisition Bid: Evonik’s decision to reject BASF SE’s takeover approach was mentioned as strengthening its market position and supporting the positive earnings outlook.
Market Reaction and Other Developments
- Leerverkauf Announcement: On 3 November 2026, a short‑sale transaction involving Evonik Industries AG (ISIN: DE000EVNK013) was registered in the Bundesanzeiger. No further details on the transaction were provided.
- Analyst Expectations: Analysts anticipate that the company will maintain a robust operating profit trajectory in the remainder of the year, with the adjusted EBITDA forecast positioned in the upper range previously set in the summer.
Summary
Evonik Industries AG demonstrated a clear improvement in third‑quarter earnings, with revenue growth, reduced net loss, and a substantial increase in adjusted EBITDA. Management’s guidance indicates confidence in meeting the upper half of its 2026 EBITDA forecast. The company’s position against competitive pressures and supply chain disruptions is highlighted as a key factor in its optimistic outlook.
